DVAX241220P12000
- 0.10
- 0.000.00%
Dynavax Technologies Newsroom
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't?
US Manufacturing Index Rises To 43, Highest Since 2020
Dynavax Technologies Down Over 7%, On Track for Largest Percent Decrease Since August 2022 -- Data Talk
Express News | Dynavax Technologies Corp: Entered $100 Mln Accelerated Share Repurchase Agreement With Goldman Sachs & Co. LLC
Dynavax Technologies Corporation (NASDAQ:DVAX) Stock Catapults 31% Though Its Price And Business Still Lag The Industry
Dynavax: Will Have $100 Million Remaining Under Buyback Program >DVAX
Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
Dynavax Rises 11% on Q3 Bottom Line Beat, 2024 Positive Net Income Expectation
Sector Update: Health Care Stocks Edge Higher Premarket Friday
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Authorizes $200 Million Stock Repurchase
Dynavax Technologies Analyst Ratings
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies: Strong Buy Rating Backed by HEPLISAV-B Growth and Strategic Initiatives
Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript
Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript Summary
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
Dynavax Technologies (DVAX) Q3 Earnings Surpass Estimates
Dynavax Technologies | 10-Q: Q3 2024 Earnings Report